19 May 2013
Keywords: analyst, estimates, third, qtr, earnings, lower, growth
Article | 12 October 1992
Lower growth is expected in the third quarter of 1992 from US
pharmaceutical companies by analyst Jonathan Gelles at New York ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 October 1992
17 May 2013
© 2013 thepharmaletter.com